Status:
RECRUITING
Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation
Lead Sponsor:
Nordsjaellands Hospital
Conditions:
Tracheal Intubation
Video Laryngoscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Globally, we are approaching 1 million surgical procedures each day. Tracheal intubation is the mainstay of securing the patient's airway and breathing during general anaesthesia. Approximately 100.00...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years
- Undergoing general anaesthesia requiring oro-tracheal intubation
- Absence of indication for rapid sequence induction
- American Society of Anesthesiologists (ASA) physical status score I - III
Exclusion
- Known allergies or contraindications to rocuronium (e.g. neuromuscular disease) or remifentanil
- Awake intubation
- Double-lumen endotracheal tube
- Oral, pharyngeal, and laryngeal surgery
- Surgical contraindication for NMBAs (e.g. use of nerve stimulator)
- Patients who are pregnant or breastfeeding
- Patients who do not understand Danish or are unable to give informed consent
Key Trial Info
Start Date :
November 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 8 2027
Estimated Enrollment :
2648 Patients enrolled
Trial Details
Trial ID
NCT06564857
Start Date
November 17 2025
End Date
April 8 2027
Last Update
December 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, NOH, Rigshospitalet
Copenhagen, Denmark, 2100
2
Department of Anesthesiology, North Zeeland Hospital
Hillerød, Denmark, 3400